NASHVILLE, Tenn. / Mar 28, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: HCA Healthcare, Inc. 1Q Earnings Release Call
When: Friday, April 21, 2023 at 9:00 am central (10:00 am eastern)
How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$381.39 |
| Daily Change: | 2.74 0.72 |
| Daily Volume: | 2,095,552 |
| Market Cap: | US$96.610B |
April 25, 2025 February 20, 2025 February 18, 2025 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
